A Multinational Phase 3 Randomized Double-Blind Placebo-Controlled Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The study will help doctors decide if adding enzalutamide to the current treatment of surgical castration or hormone therapy is better than the current treatment alone for men with this type of prostate cancer.
Description
The study will help doctors decide if adding enzalutamide to the current treatment of surgical castration or hormone therapy is better than the current treatment alone for men with this type of prostate cancer.
Details
| Age | 18years - 100years |
|---|---|
| Clinical Study Identifier | TX7508 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.